Involvement of the spinal NALP1 inflammasome in neuropathic pain and aspirin-triggered-15-epi-lipoxin A4 induced analgesia

Neuroscience

Volumn 254, Issue , 2013, Pages 230-240

  Li, Q ^a,b,c   Tian, Y ^a,b,c   Wang, Z F ^a,b,c   Liu, S B ^a,b,c   Mi, W L ^a,b,c   Ma, H J ^a,b,c   Wu, G C ^a,b,c   Wang, J ^a,b,c   Yu, J ^a,b,c   Wang, Y Q ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b Institutes of Brain Science   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Aspirin triggered 15 epi lipoxin A4; Caspase; Interleukin; NALP1 inflammasome; Neuropathic pain

Indexed keywords

ACETYLSALICYLIC ACID; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOXIN A; NACHT LEUCINE RICH REPEAT PROTEIN 1; UNCLASSIFIED DRUG; LIPOXIN; NALP1 PROTEIN, RAT; NERVE PROTEIN;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG MECHANISM; HYPERALGESIA; MALE; NERVE CELL STIMULATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY; ANIMAL; BIOSYNTHESIS; CHRONIC DISEASE; DRUG COMBINATION; DRUG EFFECTS; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; NEURALGIA; PROCEDURES; SPINAL CORD; SPRAGUE DAWLEY RAT;

ANALGESIA; ANIMALS; ASPIRIN; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; INFLAMMASOMES; INJECTIONS, SPINAL; LIPOXINS; MALE; NERVE TISSUE PROTEINS; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84886912993     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.09.028     Document Type: Article

References (42)

1. Alexander G.M., van Rijn M.A., van Hilten J.J., Perreault M.J., Schwartzman R.J. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 2005, 116:213-219.
2. Amin B., Hajhashemi V., Hosseinzadeh H., Abnous Kh. Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat. Neuroscience 2012, 224:15-25.
3. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
4. Boyden E.D., Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006, 38:240-244.
5. Chiang N., Serhan C.N., Dahlén S.E., Drazen J.M., Hay D.W., Rovati G.E., Shimizu T., Yokomizo T., Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 2006, 58:463-487.
6. Cunha T.M., Talbot J., Pinto L.G., Vieira S.M., Souza G.R., Guerrero A.T., Sonego F., Verri W.A., Zamboni D.S., Ferreira S.H., Cunha F.Q. Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1beta maturation. Mol Pain 2010, 6:63.
7. de Rivero Vaccari J.P., Lotocki G., Marcillo A.E., Dietrich W.D., Keane R.W. A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci 2008, 28:3404-3414.
8. de Rivero Vaccari J.P., Lotocki G., Alonso O.F., Bramlett H.M., Dietrich W.D., Keane R.W. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab 2009, 29:1251-1261.
9. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
10. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462.
11. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
12. Hu S., Mao-Ying Q.L., Wang J., Wang Z.F., Mi W.L., Wang X.W., Jiang J.W., Huang Y.L., Wu G.C., Wang Y.Q. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines. J Neuroinflammation 2012, 9:278.
13. Jha M.K., Jeon S., Suk K. Glia as a link between neuroinflammation and neuropathic pain. Immune Netw 2012, 12:41-47.
14. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336.
15. Kleibeuker W., Gabay E., Kavelaars A., Zijlstra J., Wolf G., Ziv N., Yirmiya R., Shavit Y., Tal M., Heijnen C.J. IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2. Brain Behav Immun 2008, 22:200-208.
16. Kohno T., Moore K.A., Baba H., Woolf C.J. Peripheral nerve injury alters excitatory synaptic transmission in lamina II of the rat dorsal horn. J Physiol 2003, 548:131-138.
17. Liao K.C., Mogridge J. Expression of Nlrp1b inflammasome components in human fibroblasts confers susceptibility to anthrax lethal toxin. Infect Immun 2009, 77:4455-4462.
18. Luo C.L., Li Q.Q., Chen X.P., Zhang X.M., Li L.L., Li B.X., Zhao Z.Q., Tao L.Y. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury. Brain Res 2013, 1502:1-10.
19. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
20. Mawhinney L.J., de Rivero Vaccari J.P., Dale G.A., Keane R.W., Bramlett H.M. Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats. BMC Neurosci 2011, 12:123.
21. McCarberg B.H., Billington R. Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care 2006, 12:S263-S268.
22. Myers R.R., Campana W.M., Shubayev V.I. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 2006, 11:8-20.
23. Pedra J.H., Cassel S.L., Sutterwala F.S. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 2009, 21:10-16.
24. Romano M. Lipoxin and aspirin-triggered lipoxins. ScientificWorldJournal 2010, 10:1048-1064.
25. Salminen A., Ojala J., Suuronen T., Kaarniranta K., Kauppinen A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med 2008, 12:2255-2262.
26. Schönbeck U., Mach F., Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998, 161:3340-3346.
27. Serhan C.N. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005, 73:141-162.
28. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008, 3:279-312.
29. Shi X., Wang L., Li X., Sahbaie P., Kingery W.S., Clark J.D. Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1beta production in keratinocytes. Anesth Analg 2011, 113:175-183.
30. Silverman W.R., de Rivero Vaccari J.P., Locovei S., Qiu F., Carlsson S.K., Scemes E., Keane R.W., Dahl G. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem 2009, 284:18143-18151.
31. Sonetti D., Peruzzi E. Neuron-microglia communication in the CNS of the freshwater snail Planorbarius corneus. Acta Biol Hung 2004, 55:273-285.
32. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
33. Sun T., Yu E., Yu L., Luo J., Li H., Fu Z. LipoxinA(4) induced antinociception and decreased expression of NF-kappaB and pro-inflammatory cytokines after chronic dorsal root ganglia compression in rats. Eur J Pain 2012, 16:18-27.
34. Sung C.S., Cherng C.H., Wen Z.H., Chang W.K., Huang S.Y., Lin S.L., Chan K.H., Wong C.S. Minocycline and fluorocitrate suppress spinal nociceptive signaling in intrathecal IL-1beta-induced thermal hyperalgesic rats. Glia 2012, 60:2004-2017.
35. Svensson C.I., Zattoni M., Serhan C.N. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J Exp Med 2007, 204:245-252.
36. Thacker M.A., Clark A.K., Marchand F., McMahon S.B. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007, 105:838-847.
37. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., Et A. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356:768-774.
38. Tschopp J., Martinon F., Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003, 4:95-104.
39. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
40. Xu J.J., Walla B.C., Diaz M.F., Fuller G.N., Gutstein H.B. Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance. Anesth Analg 2006, 103:714-720.
41. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
42. Zou J., Crews F.T. Inflammasome-IL-1beta signaling mediates ethanol inhibition of hippocampal neurogenesis. Front Neurosci 2012, 6:77.